000			01937 a2200565 4500
005			20250517120805.0
264		0	_c20180220
008			201802s 0 0 eng d
022			_a1949-2553
024	7		_a10.18632/oncotarget.12480 _2doi
040			_aNLM _beng _cNLM
100	1		_aHuang, Yao
245	0	0	_aA functional signal profiling test for identifying a subset of HER2-negative breast cancers with abnormally amplified HER2 signaling activity. _h[electronic resource]
260			_bOncotarget _cNov 2016
300			_a78577-78590 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntibodies, Monoclonal, Humanized _xpharmacology
650	0	4	_aAntineoplastic Agents, Immunological _xpharmacology
650	0	4	_aBiosensing Techniques
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aCase-Control Studies
650	0	4	_aCell Adhesion _xdrug effects
650	0	4	_aCell Line, Tumor
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aEpidermal Growth Factor _xpharmacology
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMiddle Aged
650	0	4	_aReceptor, ErbB-2 _xagonists
650	0	4	_aReceptors, Estrogen _xmetabolism
650	0	4	_aReceptors, Progesterone _xmetabolism
650	0	4	_aReproducibility of Results
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aTumor Cells, Cultured
700	1		_aBurns, David J
700	1		_aRich, Benjamin E
700	1		_aMacNeil, Ian A
700	1		_aDandapat, Abhijit
700	1		_aSoltani, Sajjad M
700	1		_aMyhre, Samantha
700	1		_aSullivan, Brian F
700	1		_aFurcht, Leo T
700	1		_aLange, Carol A
700	1		_aHurvitz, Sara A
700	1		_aLaing, Lance G
773	0		_tOncotarget _gvol. 7 _gno. 48 _gp. 78577-78590
856	4	0	_uhttps://doi.org/10.18632/oncotarget.12480 _zAvailable from publisher's website
999			_c26492361 _d26492361